IMRX
Immuneering Corp
NASDAQ · Healthcare · Biotechnology · US
$3.75
−6.84%Next report
Analyst consensus
- Next report date
- Mar 11, 2027
- EPS estimate
- -$0.34
- Revenue estimate
- —
Latest reported
- Last report date
- Oct 29, 2026
- EPS actual
- -$0.37
- EPS estimate
- -$0.31
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 5
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +12.2%
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Oct 29, 2026 | -$0.31 | -$0.37 | Miss -21.30% | — |
| Aug 5, 2026 | -$0.26 | -$0.27 | Miss -2.16% | — |
| May 15, 2026 | -$0.30 | -$0.21 | Beat 30.00% | — |
| Mar 6, 2026 | -$0.31 | -$0.18 | Beat 42.39% | — |
| Nov 12, 2025 | -$0.37 | -$0.38 | Miss -2.70% | — |
| Aug 13, 2025 | -$0.40 | -$0.40 | In line | — |
| Mar 20, 2025 | -$0.42 | -$0.58 | Miss -38.10% | — |
| Mar 1, 2024 | -$0.48 | -$0.52 | Miss -8.33% | -$94.4M |
| Nov 9, 2023 | -$0.51 | -$0.43 | Beat 15.69% | — |
| Aug 3, 2023 | -$0.54 | -$0.43 | Beat 20.37% | $94.4M |
| May 4, 2023 | -$0.54 | -$0.51 | Beat 5.56% | — |
| Mar 6, 2023 | -$0.58 | -$0.50 | Beat 13.79% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 11, 2027